Clinical Trials on Esophageal Atresia

Total 4676 results

Vrije Universiteit Brussel

Completed

Safety Study of Airway Clearance Techniques in Infants.

Gastro-esophageal Reflux

Belgium
National Cancer Institute (NCI)

Recruiting

Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer

Neoplasms | Esophageal Neoplasms | Esophagus Cancer | Esophagus Neoplasm | Neoplasms, Esophageal | Esophageal Cancer (EsC)

United States
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Spleen Stiffness as a Measure to Assess the REsponse to β Blocker Therapy (SPARE-B)

High Risk Esophageal Varices

India
Mayo Clinic

Withdrawn

HRIM vs Mucosal Impedance in GERD Participants

Gastro-esophageal Reflux Disease (GERD)

United States
Mayo Clinic

Terminated

Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

Esophageal Cancer | Cancer of the Esophagus | Esophageal Neoplasm | Esophagus Cancer | Cancer of Esophagus | Neoplasm, Esophageal | Esophageal Neoplasms Malignancy Unspecified | Esophageal Neoplasms Malignant

United States
Medtronic - MITG

Withdrawn

Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance (Encore)

Gastro Esophageal Reflux Disease

Israel
MAAB (Shanghai) Medical Device Limited
RD Biomed Ltd

Completed

Validation of a Non-invasive In-vitro Diagnostic Test (Peptest) Against Other Diagnostic Methods for GERD (PEPTESTCN)

Gastro-esophageal Reflux Disease

China
Yonsei University

Completed

A Study of Disposable Transnasal Esophagoscope

Gastroesophageal Reflux | Esophageal Varices | Esophageal Disease

Korea, Republic of
University Hospital of Cologne

Active, not recruiting

Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent) (VACStent)

Esophageal Cancer | Esophageal Diseases | Esophageal Achalasia | Perforation Esophagus

Germany
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Gastroesophageal Junction Adenocarcinoma | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 | Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 | Pathologic Stage IIA Esophageal... and other conditions

United States
Children's Hospital of Fudan University

Recruiting

Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy

Cholangitis | Anti-Bacterial Agents | Biliary Atresia

China
Aswan University Hospital

Completed

Outcome of Kasai Portoenterostomy in Biliary Atresia in Upper Egypt

Biliary Atresia

Egypt
Naved Alizai
Baxter Healthcare Corporation

Unknown

Trail to Investigate the Effectiveness of CoSeal in Reducing Adhesions Following the Kasai Hepatoportoenterostomy for Biliary Atresia (CoSRCT)

Biliary Atresia

United Kingdom
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Terminated

Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery

Adenocarcinoma of the Gastroesophageal Junction | Stage IIIA Esophageal Adenocarcinoma | Stage IIIB Esophageal Adenocarcinoma | Stage IIIC Esophageal Adenocarcinoma | Stage IIB Esophageal Adenocarcinoma

United States
James J. Peters Veterans Affairs Medical Center

Unknown

GERD and Anti-Reflux Therapy Between Able-bodied and SCI Individuals

Gastro Esophageal Reflux Disorder

United States
Maastricht University Medical Center

Completed

Epithelial Damage in GERD

Gastro-esophageal Reflux Disease

Netherlands
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer

Gastroesophageal Junction Adenocarcinoma | Stage IB Esophageal Adenocarcinoma AJCC v7 | Stage II Esophageal Adenocarcinoma AJCC v7 | Stage IIA Esophageal Adenocarcinoma AJCC v7 | Stage IIB Esophageal Adenocarcinoma AJCC v7 | Stage IIIA Esophageal Adenocarcinoma AJCC v7 | Stage IIIB Esophageal...

United States
Hebei Medical University Fourth Hospital

Recruiting

Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal Cancer (Best-EEC)

Esophageal Carcinoma

China
University Medical Center Mainz

Recruiting

RAMIE Versus MIE for Resectable Esophageal Cancer, a Randomized Controlled Trial (ROBOT-2 Trial). (ROBOT-2)

Esophageal Adenocarcinoma

Germany
University Medical Center Groningen

Terminated

BReath Hold TecHniquEs for Radiotherapy of Esophageal Carcinoma (BROTHER)

Esophageal Cancer

Netherlands
Jiangsu HengRui Medicine Co., Ltd.

Completed

Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer

Esophageal Carcinoma

China
University of Rochester

Active, not recruiting

Induction Chemotherapy for Locally Advanced Esophageal Cancer

Esophageal Carcinoma

United States
UMC Utrecht

Completed

Robot-assisted Thoraco-laparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy (ROBOT)

Esophageal Cancer | Esophageal Carcinoma

Netherlands
Emory University
Novartis

Completed

Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer

Esophageal Cancer | Neoplasms, Esophageal

United States
Cancer Institute and Hospital, Chinese Academy...
Zhejiang Cancer Hospital; Fujian Cancer Hospital; Henan Cancer Hospital; Tongji... and other collaborators

Unknown

Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node Involvement

Esophageal Cancer

China
Roswell Park Cancer Institute

Withdrawn

Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer

Esophageal Neoplasm
University of Michigan Rogel Cancer Center

Completed

Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma

Esophageal Cancer

United States
NYU Langone Health

Withdrawn

Preventing Esophageal Stent Migration in Esophageal Strictures

Stent Migration

United States
Reckitt Benckiser Healthcare (UK) Limited

Completed

Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study

Gastro-esophageal Reflux Disease (GERD)

China
Western Sydney Local Health District

Recruiting

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study (ANZ UGI)

Gastric Cancer | Esophageal Neoplasms | Neuroendocrine Tumors | Gastric Adenocarcinoma | Cancer of Stomach | Oesophageal Cancer | Gastric Neoplasm | GIST | GI Cancer

Australia
Fundacion Miguel Servet

Unknown

Pressure and Flow Study Before and After Treatments for EMD. The pFlow Study (pFlow)

Esophageal Motility Disorders | Gastro-esophageal Reflux

Spain
Biotech Pharmaceutical Co., Ltd.

Completed

Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer

Esophageal

China
Reckitt Benckiser Healthcare (UK) Limited

Terminated

Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients

Gastro-esophageal Reflux Disease (GERD)

China
University Hospital, Bordeaux

Unknown

FODMAPs and Refractory GERD (EFFORR)

Gastro-esophageal Reflux Disease (GERD)

France
The First Affiliated Hospital of Henan University...

Unknown

Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer

Stage III Esophageal Squamous Cell Carcinoma | Stage II Esophageal Squamous Cell Carcinoma | Stage I Esophageal Adenocarcinoma | Stage II Esophageal Adenocarcinoma | Stage III Esophageal Adenocarcinoma | Stage I Esophageal Squamous Cell Carcinoma

China
Memorial Sloan Kettering Cancer Center

Completed

Effect of Affective Content on Drug Induced Amnesia of Episodic Memory

Memory Losses | Amnesia-Memory Loss

United States
Klinikum Garmisch-Patenkirchen

Not yet recruiting

ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease (ARMA)

Reflux, Gastroesophageal | Gastro-esophageal Reflux

Germany
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Phase II Study of HR070803 in the Treatment of Advanced Esophageal Cancer

Advanced Esophageal Cancer

China
West China Hospital

Completed

Short-term Outcomes of ERAS Protocol in RAME for Esophageal Cancer

Esophageal Cancer Patients

China
Tianjin Medical University Cancer Institute and...

Unknown

Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESO

Unresectable Esophageal Cancer

China
University Hospitals, Leicester
National Institute for Health Research, United Kingdom; University of Leicester

Completed

Barrett&Apos;s Intervention for Dysplasia by Endoscopy (BRIDE)

Barretts Esophagus | Esophageal High-Grade Intraepithelial Neoplasia | Esophageal Cancer Stage I

United Kingdom
National Cancer Institute (NCI)

Active, not recruiting

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Recurrent Esophageal Carcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Stage IV Esophageal Cancer AJCC v7 | Metastatic Esophageal Squamous Cell Carcinoma | Metastatic Esophageal Adenocarcinoma | Recurrent Gastroesophageal Junction Adenocarcinoma | Recurrent Esophageal Adenocarcinoma and other conditions

United States
University Medical Center Groningen

Completed

PET-CT vs DWI-MRI in Response Evaluation in Esophageal Cancer (PET/MRI-EC)

Esophageal Tumor

Netherlands
Biotech Pharmaceutical Co., Ltd.

Completed

Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

Advanced Esophageal

China
Chinese University of Hong Kong

Completed

Surgery or Chemoradiation for Esophageal Cancer

Esophageal Cancers
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer

Gastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7 | Malignant Neoplasm of the Cervical Esophagus | Malignant Neoplasm...

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

Stage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer... and other conditions

United States
University of Nebraska
National Cancer Institute (NCI)

Terminated

Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

Esophageal Adenocarcinoma | Adenocarcinoma of the Gastroesophageal Junction | Stage IIB Esophageal Cancer | Stage IIA Esophageal Cancer

United States
Bayside Health
Monash University; The Alfred

Unknown

The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung Transplantation

Cystic Fibrosis

Australia
Société Française d'Endoscopie Digestive

Completed

Evaluation of the Effectiveness of Endoscopic "Rendez-vous" Technique Foresophageal Reconstructions for the Treatment of a Total and Extensive Disruption of the Esophagus

Esophageal Obstruction | Esophageal Disruption

France

Clinical Trials on Esophageal Atresia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations